Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Income Tax Expense

$121.00M

Quarterly · Period ending: Jun 30, 2026 · USD

TEVA Income Tax Expense

Latest reported$121.00Mperiod endingJun 30, 2026

TEVA Quarterly Income Tax ($0.00 → $121.00M)

Quarterly income tax expense

High-resolution chart · PNG

TEVA income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2026	121,000,000
Mar 31, 2026	67,000,000
Dec 31, 2025	-390,000,000
Sep 30, 2025	214,000,000
Jun 30, 2025	-78,000,000
Mar 31, 2025	74,000,000
Dec 31, 2024	28,000,000
Sep 30, 2024	69,000,000
Jun 30, 2024	630,000,000
Mar 31, 2024	-52,000,000
Dec 31, 2023	41,000,000
Sep 30, 2023	-12,000,000
Jun 30, 2023	15,999,999
Mar 31, 2023	18,999,999
Dec 31, 2022	154,000,000
Sep 30, 2022	107,000,000
Jun 30, 2022	899,999,999
Mar 31, 2022	2,000,000
Dec 31, 2021	-24,000,000
Sep 30, 2021	76,000,000
Jun 30, 2021	98,000,000
Mar 31, 2021	62,000,000
Dec 31, 2020	20,999,999
Sep 30, 2020	16,000,000
Jun 30, 2020	-104,000,000
Mar 31, 2020	-59,000,000
Dec 31, 2019	119,000,000
Sep 30, 2019	11,000,000
Jun 30, 2019	-179,000,000
Mar 31, 2019	9,000,000
Dec 31, 2018	-139,000,000
Sep 30, 2018	-26,000,000
Jun 30, 2018	-76,000,000
Mar 31, 2018	46,000,000
Dec 31, 2017	-1,471,000,000
Sep 30, 2017	-494,000,000
Jun 30, 2017	-22,000,000
Mar 31, 2017	54,000,000
Dec 31, 2016	57,000,000
Sep 30, 2016	207,000,000
Jun 30, 2016	29,000,000
Mar 31, 2016	228,000,000
Dec 31, 2015	249,000,000
Sep 30, 2015	193,000,000
Jun 30, 2015	88,000,000
Mar 31, 2015	104,000,000
Dec 31, 2014	186,000,000
Sep 30, 2014	160,000,000
Jun 30, 2014	102,000,000
Mar 31, 2014	143,000,000
Dec 31, 2013	114,000,000
Sep 30, 2013	12,000,000
Jun 30, 2013	-222,000,000
Mar 31, 2013	53,000,000
Dec 31, 2012	-110,000,000
Sep 30, 2012	-57,000,000
Jun 30, 2012	39,000,000
Mar 31, 2012	-9,000,000
Dec 31, 2011	18,000,000
Sep 30, 2011	33,000,000
Jun 30, 2011	27,000,000
Mar 31, 2011	49,000,000
Dec 31, 2010	619,000,000
Sep 30, 2010	133,000,000
Jun 30, 2010	118,000,000
Mar 31, 2010	85,000,000
Dec 31, 2009	6,000,000
Sep 30, 2009	49,000,000
Jun 30, 2009	98,000,000
Mar 31, 2009	25,000,000
Dec 31, 2008	-23,000,000
Sep 30, 2008	47,000,000
Jun 30, 2008	68,000,000
Mar 31, 2008	93,000,000
Dec 31, 2007	84,000,000
Sep 30, 2007	125,000,000
Jun 30, 2007	113,000,000
Mar 31, 2007	75,000,000
Dec 31, 2006	-76,900,000
Sep 30, 2006	87,200,000
Jun 30, 2006	96,500,000
Mar 31, 2006	48,200,000
Dec 31, 2005	48,100,000
Sep 30, 2005	50,900,000
Jun 30, 2005	66,100,000
Mar 31, 2005	71,100,000
Dec 31, 2004	70,500,000
Sep 30, 2004	73,900,000
Jun 30, 2004	68,800,000
Mar 31, 2004	54,000,000
Dec 31, 2003	49,800,000
Sep 30, 2003	39,100,000
Jun 30, 2003	54,900,000
Mar 31, 2003	37,700,000
Dec 31, 2002	30,900,000
Sep 30, 2002	18,200,000
Jun 30, 2002	17,400,000
Mar 31, 2002	18,300,000
Dec 31, 2001	12,750,000
Sep 30, 2001	17,500,000